Based on the Neuronetics Inc stock forecast from 3 analysts, the average analyst target price for Neuronetics Inc is USD 5.50 over the next 12 months. Neuronetics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Neuronetics Inc is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, Neuronetics Inc’s stock price was USD 3.55. Neuronetics Inc’s stock price has changed by -3.53% over the past week, -29.98% over the past month and -14.46% over the last year.
No recent analyst target price found for Neuronetics Inc
No recent average analyst rating found for Neuronetics Inc
Company Overview Neuronetics Inc
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. Read Less
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office...Read More
Frequently Asked Questions About Neuronetics Inc (STIM) Stock
Based on ratings from 3 analysts Neuronetics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 3 buy, sell and hold ratings.
Unfortunately we do not have enough data on STIM's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for STIM is USD 5.50 over the next 12 months. The maximum analyst target price is USD 8 while the minimum anlayst target price is USD 3.
STIM stock's Price/Earning ratio is 0.10.
Our analysis grades STIM stock's Price / Earning ratio at A+. This means that STIM stock's Price/Earning ratio is above 0% of the stocks in the Diagnostics & Research sector in the NSD exchange.
Based on this STIM may be undervalued for its sector.
The last closing price of STIM's stock was USD 3.55.
The most recent market capitalization for STIM is USD 0.33B.
Based on targets from 3 analysts, the average taret price for STIM is projected at USD 5.50 over the next 12 months.
This means that STIM's stock price may go up by +54.93% over the next 12 months.
We can't find any ETFs which contains Neuronetics Inc's stock.
As per our most recent records Neuronetics Inc has 203 Employees.
Neuronetics Inc's registered address is 3222 Phoenixville Pike, Malvern, PA, United States, 19355.
You can get more information about it from Neuronetics Inc's website at https://neurostar.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Frequently Asked Questions About Neuronetics Inc (STIM) Stock
Based on ratings from 3 analysts Neuronetics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 3 buy, sell and hold ratings.
Unfortunately we do not have enough data on STIM's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for STIM is USD 5.50 over the next 12 months. The maximum analyst target price is USD 8 while the minimum anlayst target price is USD 3.
STIM stock's Price/Earning ratio is 0.10.
Our analysis grades STIM stock's Price / Earning ratio at A+. This means that STIM stock's Price/Earning ratio is above 0% of the stocks in the Diagnostics & Research sector in the NSD exchange.
Based on this STIM may be undervalued for its sector.
The last closing price of STIM's stock was USD 3.55.
The most recent market capitalization for STIM is USD 0.33B.
Based on targets from 3 analysts, the average taret price for STIM is projected at USD 5.50 over the next 12 months.
This means that STIM's stock price may go up by +54.93% over the next 12 months.
We can't find any ETFs which contains Neuronetics Inc's stock.
As per our most recent records Neuronetics Inc has 203 Employees.
Neuronetics Inc's registered address is 3222 Phoenixville Pike, Malvern, PA, United States, 19355.
You can get more information about it from Neuronetics Inc's website at https://neurostar.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for STIM !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
